cridanimod | |
---|---|
Trade Name | |
Orphan Indication | Endometrial cancer |
USA Market Approval | USA |
USA Designation Date | 2011-01-12 00:00:00 |
Sponsor | Xenetic Biosciences, Inc.;99 Hayden Avenue, Suite 230;Lexington, Massachusetts, 02421 |
Related Access Program